- Home
- KTCC vs RLYB Comparison
KTCC vs RLYB Comparison
Compare KTCC & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- RLYB
- Stock Information
- Founded
- KTCC 1969
- RLYB 2018
- Country
- KTCC United States
- RLYB United States
- Employees
- KTCC N/A
- RLYB N/A
- Industry
- KTCC Electrical Products
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- RLYB Health Care
- Exchange
- KTCC Nasdaq
- RLYB Nasdaq
- Market Cap
- KTCC 51.2M
- RLYB 46.1M
- IPO Year
- KTCC N/A
- RLYB 2021
- Fundamental
- Price
- KTCC $5.78
- RLYB $1.11
- Analyst Decision
- KTCC
- RLYB Buy
- Analyst Count
- KTCC 0
- RLYB 6
- Target Price
- KTCC N/A
- RLYB $8.30
- AVG Volume (30 Days)
- KTCC 29.2K
- RLYB 44.1K
- Earning Date
- KTCC 10-29-2024
- RLYB 11-07-2024
- Dividend Yield
- KTCC N/A
- RLYB N/A
- EPS Growth
- KTCC N/A
- RLYB N/A
- EPS
- KTCC N/A
- RLYB N/A
- Revenue
- KTCC $559,396,000.00
- RLYB $299,000.00
- Revenue This Year
- KTCC N/A
- RLYB N/A
- Revenue Next Year
- KTCC N/A
- RLYB N/A
- P/E Ratio
- KTCC N/A
- RLYB N/A
- Revenue Growth
- KTCC N/A
- RLYB N/A
- 52 Week Low
- KTCC $3.60
- RLYB $1.08
- 52 Week High
- KTCC $6.14
- RLYB $4.60
- Technical
- Relative Strength Index (RSI)
- KTCC 65.29
- RLYB 49.41
- Support Level
- KTCC $5.40
- RLYB $1.09
- Resistance Level
- KTCC $5.79
- RLYB $1.18
- Average True Range (ATR)
- KTCC 0.35
- RLYB 0.04
- MACD
- KTCC -0.02
- RLYB 0.00
- Stochastic Oscillator
- KTCC 62.50
- RLYB 33.33
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.